Stock-Based Compensation	9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Note 8 – Stock-Based Compensation The Company grants time-based restricted stock awards (“time-based RSAs”) to employees and directors under the Blue Ridge Bankshares, Inc. 2023 Stock Incentive Plan. Time-based RSAs are considered fixed awards as the number of shares and fair value are both known at the date of grant, and the fair value of the award at the grant date is amortized over the requisite service period, which is generally three years. Beginning in 2022, the Company began granting performance-based restricted stock awards (“PSAs”) to employees, in addition to time-based RSAs. PSAs vest at the end of a three-year period contingent on the Company's achievement of financial goals and are being expensed on a straight-line basis over the same period with adjustments periodically based on projected achievement of the performance target, which may change the number of PSA shares that will ultimately vest. Time-based RSAs carry voting and dividend rights, while PSAs carry voting rights and are subject to deferred dividend payout restrictions. Compensation expense recognized in the consolidated statements of operations related to time-based RSAs and PSAs, net of forfeitures, was $554 thousand and $1.5 million for the three and nine months ended September 30, 2023, respectively, and was $415 thousand and $1.1 million for the three and nine months ended September 30, 2022, respectively. During the nine months ended September 30, 2023, grants of 289,981 time-based RSAs or PSAs were made, while forfeitures relating to 46,846 shares of the Company's common stock resulted due to employee terminations. As of September 30, 2023, time-based RSAs and PSAs relating to 438,974 shares of the Company's common stock were outstanding, and unrecognized compensation expense related to these awards totaled $3.2 million. During the first nine months of 2023, stock options relating to 3,750 shares were exercised and stock options relating to 15,058 shares expired, resulting in stock options relating to 33,866 shares remaining outstanding as of September 30, 2023. These options were assumed by the Company in connection with the Bay Banks Merger and expire between March 2024 and December 2029.

Stock-Based Compensation

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Note 8 – Stock-Based Compensation

The Company grants time-based restricted stock awards (“time-based RSAs”) to employees and directors under the Blue Ridge Bankshares, Inc. 2023 Stock Incentive Plan. Time-based RSAs are considered fixed awards as the number of shares and fair value are both known at the date of grant, and the fair value of the award at the grant date is amortized over the requisite service period, which is generally three years. Beginning in 2022, the Company began granting performance-based restricted stock awards (“PSAs”) to employees, in addition to time-based RSAs. PSAs vest at the end of a three-year period contingent on the Company's achievement of financial goals and are being expensed on a straight-line basis over the same period with adjustments periodically based on projected achievement of the performance target, which may change the number of PSA shares that will ultimately vest. Time-based RSAs carry voting and dividend rights, while PSAs carry voting rights and are subject to deferred dividend payout restrictions.

Compensation expense recognized in the consolidated statements of operations related to time-based RSAs and PSAs, net of forfeitures, was $554 thousand and $1.5 million for the three and nine months ended September 30, 2023, respectively, and was $415 thousand and $1.1 million for the three and nine months ended September 30, 2022, respectively. During the nine months ended September 30, 2023, grants of 289,981 time-based RSAs or PSAs were made, while forfeitures relating to 46,846 shares of the Company's common stock resulted due to employee terminations. As of September 30, 2023, time-based RSAs and PSAs relating to 438,974 shares of the Company's common stock were outstanding, and unrecognized compensation expense related to these awards totaled $3.2 million.

During the first nine months of 2023, stock options relating to 3,750 shares were exercised and stock options relating to 15,058 shares expired, resulting in stock options relating to 33,866 shares remaining outstanding as of September 30, 2023. These options were assumed by the Company in connection with the Bay Banks Merger and expire between March 2024 and December 2029.